Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. April 2026 17:30 ET | Quelle: Panakeia Technologies Ltd

Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026

CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for...
29. Januar 2026 09:00 ET | Quelle: Panakeia Technologies Ltd

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer
22. Januar 2025 04:00 ET | Quelle: Panakeia Technologies Ltd

Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium

PANProfiler Colon achieved 92.69% positive and 94.05% negative agreement for MSI/dMMR detection Real-world blinded validation on 3178 colorectal cancer patient samplesData to be presented at the...
14. Januar 2025 07:30 ET | Quelle: Panakeia Technologies Ltd

Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancer

PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samplesEntirely digital, AI-driven molecular profiling tool for rapid treatment decision making for personalised...